Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Dave Barry Plastics, further expanding the company’s life sciences portfolio.
Ireland-based Dave Barry Plastics designs and manufactures plastic product solutions for life science and healthcare technology industries. These types of product solutions are used in clean rooms, which are specially designed to reduce the risk of contamination during the manufacturing, packaging, and storage process. Dave Barry Plastics will join the Life Sciences platform within the Precision and Science Technologies (P&ST) segment.
“The acquisition of Dave Barry Plastics reflects our commitment to expanding our portfolio with innovative, high-performance solutions,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “Their expertise in custom plastic products for the biopharmaceutical, pharmaceutical, and medical device industries will greatly enhance Ingersoll Rand’s life science capabilities. We are excited to welcome the Dave Barry Plastics team to Ingersoll Rand as we continue driving growth through purposeful, direct investments.”
Ingersoll Rand Inc. (NYSE: IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and industrial solutions. Supported by over 80+ respected brands, our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency.